Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
The 92nd Annual Meeting of the Japanese Pharmacological Society
Session ID : 92_3-O-04
Conference information

Oral Sessions
Molecular mechanisms of diastolic dysfunction in diabetic cardiomyopathy
*Yoshinori MikamiShogo HamaguchiMasanori ItoShingo MurakamiTaichiro TomidaDaisuke OhshimaIyuki NamekataHikaru TanakaSatomi Adachi-Akahane
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

The early stage of diabetes mellitus (DM)-related cardiomyopathy (DMCM) is characterized by left ventricular (LV) diastolic dysfunction. The aim of this study was to elucidate the mechanism of the defective Ca2+ signaling underlying diastolic dysfunction in DMCM. In the streptozotocin (STZ)-induced DMCM model mice 4 weeks after STZ treatment, diastolic function was impaired without reduction of ejection fraction. In the isolated LV myocytes from DM mice, the Ca2+ transient decay rate was slower than that from control. In the ventricle of DM mice, the expression level of junctophilin2 protein was significantly lower, although expression levels of CaV1.2, RyR2 and SERCA2 were the same as those of control mice, suggesting that uncoupling of dyad junction starts at the early stage. The phosphorylation level of phospholamban (p-PLN) was significantly lower. Insulin treatment recovered the p-PLN level and the relaxation rate of the isolated ventricular myocardium from DM mice. Furthermore, PKA-independent insulin/PKG signaling turned out to be required for maintaining basal p-PLN. These results indicate that the reduction of p-PLN caused by insulin signaling defect is responsible for the LV diastolic dysfunction in the early stage of DMCM.

Content from these authors
© 2019 The Authors(s)
Previous article Next article
feedback
Top